Cite
HARVARD Citation
Bonaca, M. et al. (2022). Randomized, Placebo-Controlled Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Lecithin Cholesterol Acyltransferase in Acute ST-Segment–Elevation Myocardial Infarction: Results of REAL-TIMI 63B. Circulation. 146 (12), pp. 907-916. [Online].